DMII supply chain intelligence for Drugs Made In America Acquisition II Corp.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Drugs Made In America Acquisition II Corp. (DMII) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ALEUTIAN-EQUITY-HOLDINGS-LLC | ALEUTIAN-EQUITY-HOLDINGS-LLC | 92% | Pursuant to the CEO Compensation Agreement: ● Mr. Bendelac is entitled to compensation of $4,500 per month, of which $2,500 is payable currently and up to $2,000 may be deferred based on the Company’… |
| DRUGS-MADE-IN-AMERICA-ACQUISITION-II-LLC | DRUGS-MADE-IN-AMERICA-ACQUISITION-II-LLC | 92% | We had an agreement to pay Drugs Made In America Acquisition II LLC (the “Sponsor”) a total of $10,000 per month for office space, administrative and support services which has been cancelled in Marc… |
| TITAN-ADVISORY-SERVICES-LLC | TITAN-ADVISORY-SERVICES-LLC | 92% | The Consulting Agreement included a Statement of Work (the “ SoW ”) for the services to be rendered by Mr. Elmasri and the $3,500 monthly compensation to be paid by the Company. |
| ALPHA-MULTI-FAMILY-OFFICE | ALPHA-MULTI-FAMILY-OFFICE | 90% | The Bridge Loan represented an initial loan towards a contemplated $1,400,000 financing (the “ Convertible Notes Financing ”) pursuant to previously-disclosed Letter of Intent (“ LOI ”). |
| PRIOR-CFO | PRIOR-CFO | 90% | The Company’s prior CFO (“Prior CFO”) is a partner in the advisory firm through which he provided accounting services to the Company. |
| ADMINISTRATIVE-SERVICES-AGREEMENT | ADMINISTRATIVE-SERVICES-AGREEMENT | 80% | Commencing on September 24, 2025, the Company entered into an Administrative Services Agreement, pursuant to which the Company has agreed to pay the Sponsor or an affiliate $ 10,000 for office space,… |
| DLA-LLC | DLA-LLC | 80% | From June 2019 to August 2020, he was Managing Director at DLA LLC. |
| PINE-HILL-GROUP-LLC | PINE-HILL-GROUP-LLC | 80% | From March 2018 to June 2019, he worked as Senior Director for Pine Hill Group LLC, a boutique accounting and transaction advisory firm. |
| PRICEWATERHOUSECOOPERS-LLP | PRICEWATERHOUSECOOPERS-LLP | 80% | From September 2007 to March 2018, Mr. Elmasri advanced through a series of progressively responsible roles, culminating in the position of Senior Manager for PricewaterhouseCoopers LLP |
| SP-ASSOCIATES-CORP | SP-ASSOCIATES-CORP | 80% | He is also currently a business consultant and has served as president and director of SP Associates Corp., a management consulting and corporate advisory services firm since March 2016. |
| SPONSOR | SPONSOR | 80% | On September 5, 2024, the Sponsor issued an unsecured promissory note to the Company |
| OPENCAP-GLOBAL-INC | OPENCAP-GLOBAL-INC | 75% | Starting in March, 2018, he was appointed and has continued to serve as a director for Opencap Global Inc. |
| ROGER-E-BENDELAC | ROGER-E-BENDELAC | 70% | On April 22, 2026, the Company entered into a compensation agreement (the “CEO Compensation Agreement”) with Aleutian Equity Holdings LLC, an affiliate of Roger E. Bendelac, the Company’s Chief Execu… |
| WORKING-CAPITAL-LOANS | WORKING-CAPITAL-LOANS | 70% | In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obliga… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| DMAA | Drugs Made In America Acquisition Corp. | 72% | e, La Jolla, California. Myron W. Shulgan KC serves as a member of our board of directors. In addition, Mr. Shulgan has served as a member of the board of directors of Drugs Made In America Acquisiti… |
| DMAA | Drugs Made In America Acquisition Corp. | 72% | Reciprocal relationship from DMAA graph: Reciprocal relationship from DMII graph: e, La Jolla, California. Myron W. Shulgan KC serves as a member of our board of directors. In addition, Mr. Shulgan h… |
| APEX-AI-SOLUTIONS-LIMITED | APEX-AI-SOLUTIONS-LIMITED | 62% | . ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. Not applicable. 20 PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. Directors and Executive Of… |
| DLA-LLC | DLA-LLC | 62% | . ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. Not applicable. 20 PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. Directors and Executive Of… |
| DRUGS-MADE-IN-AMERICA-ACQUISITION-II-LLC | DRUGS-MADE-IN-AMERICA-ACQUISITION-II-LLC | 62% | ant. In the event that we decide to enter into our initial business combination with a target business that does not meet the above criteria and guidelines, we will disclose that the target business … |
| MYRON-SHULGAN-PROFESSIONAL-CORPORATION | MYRON-SHULGAN-PROFESSIONAL-CORPORATION | 62% | e, La Jolla, California. Myron W. Shulgan KC serves as a member of our board of directors. In addition, Mr. Shulgan has served as a member of the board of directors of Drugs Made In America Acquisiti… |
| OPENCAP-GLOBAL-INC | OPENCAP-GLOBAL-INC | 62% | . ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. Not applicable. 20 PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. Directors and Executive Of… |
| RB-CONSULTING-GROUP-LTD | RB-CONSULTING-GROUP-LTD | 62% | . ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. Not applicable. 20 PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. Directors and Executive Of… |
| SP-ASSOCIATES-CORP | SP-ASSOCIATES-CORP | 62% | . ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. Not applicable. 20 PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. Directors and Executive Of… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| DMII-DEBT | Debt stack $450,000 | 90% | Market cache reports total debt of $450,000. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| DMII-OWNER-MMCAP-INTERNATIONAL-INC-SPC | MMCAP International Inc. SPC | 90% | 13F overlay lists MMCAP International Inc. SPC as top holder; 68 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| DMAA | Drugs Made In America Acquisition Corp. | 38.88 | 1 | ['customer'] |